Dina Began, MD
Dermatology · Hoboken, NJNPI 1497862346
Payments from drug & device makers
Across 548 payments — averaging $26.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Galderma Laboratories, L.p.$1K
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$1K
- Pfizer$1K
- Arcutis Biotherapeutics, Inc.$957
- Dermavant Sciences, Inc.$932
- plus $8K from 30 others
What the payments were for
- Consulting fees$9006%
- Food & beverage$13,26792%
- Education$2332%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 70 | $1,293 |
| Galderma Laboratories, L.p. | 20 | $1,252 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 43 | $1,142 |
| Pfizer | 57 | $1,065 |
| Arcutis Biotherapeutics, Inc. | 63 | $957 |
| Dermavant Sciences, Inc. | 37 | $932 |
| Sanofi | 26 | $924 |
| Medimetriks Pharmaceuticals, Inc. | 1 | $900 |
| LEO Pharma Inc. | 35 | $879 |
| Sun Pharmaceutical Industries Inc. | 34 | $870 |
| Johnson & Johnson | 23 | $744 |
| Regeneron Healthcare Solutions, Inc. | 12 | $519 |
| Incyte Corporation | 14 | $439 |
| Amgen | 16 | $438 |
| Mayne Pharma Commercial LLC | 15 | $342 |
| E.r. Squibb & Sons, L.L.C. | 16 | $333 |
| Almirall LLC | 10 | $242 |
| Journey Medical Corporation | 10 | $241 |
| UCB, Inc. | 7 | $233 |
| Novartis | 6 | $127 |
| EPI Health, LLC | 6 | $81 |
| Lilly USA, LLC | 5 | $81 |
| Botanix SB Inc | 3 | $50 |
| Merck | 3 | $40 |
| Exact Sciences | 1 | $35 |
| Sandoz | 2 | $31 |
| Prugen, Inc. Pharmaceuticals | 3 | $29 |
| Mission Pharmacal Company | 2 | $28 |
| VYNE Pharmaceuticals Inc. | 1 | $27 |
| Boston Scientific | 1 | $24 |
| Mimedx Group, Inc. | 1 | $20 |
| Fidia Pharma USA Inc. | 1 | $19 |
| Dermira, Inc. | 1 | $17 |
| Organon | 1 | $17 |
| Cipher Pharmaceuticals US LLC | 1 | $16 |
| Paratek Pharmaceuticals, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$14,400 in reported general payments places this provider in the 85th percentile of 394 dermatology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tacrolimus | 12 | $3,622 |
| Clobetasol Propionate | 20 | $923 |
| Ketoconazole | 53 | $594 |
| Triamcinolone Acetonide | 28 | $244 |
| Ammonium Lactate | 15 | $139 |
| Mupirocin | 14 | $90 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Hoboken
- Linda Cappiello-LindsleyHoboken$2.3M
- Adolfo Fernandez ObregonHoboken$1.1M
- Jerry BagelEast Windsor$15.4M
- Jonathan DosikGlen Rock$8.4M
- Omar NoorSomerset$4.6M
- Winston MoyDenville$1.8M
- Brian KeeganEast Windsor$1.7M
- Jeanine DownieMontclair$1.2M
- Mital Patel CohenFlorham Park$799K
- Ronald BernardinVoorhees$688K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.